Daunomycin and tumour lysis syndrome Patient Reports February 11, 2012

Daunomycin Side Effects Report #4568998-9
Daunomycin side effect was reported by a Health Professional from on Jan 26, 2005. Male patient, 72 years of age, weighting 209.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, coma, pulmonary alveolar haemorrhage, tumour lysis syndrome. Daunomycin dosage: 45 MG/M2 OTHER. During the same period patient was treated with CYTARABINE, HYDREA. Patient was hospitalized. Patient died on 12/03/2004.

Daunomycin Side Effects Report #4708267-7
Daunomycin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2005. Male patient, weighting 178.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: dialysis , tumour lysis syndrome. Daunomycin dosage: 60MG/M2 IVP ON DAYS 1, 8, 15, AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, ELSPAR, METHOTREXATE. Patient recovered.

Daunomycin Side Effects Report #4626828-0
Daunomycin side effect was reported by a Consumer or non-health professional from on Apr 01, 2005. Male patient, weighting 178.1 lb, was treated with Daunomycin. After drug was administered, patient experienced the following side effects: dialysis , tumour lysis syndrome. Daunomycin dosage: 60 MG/M2 IVP ON DAYS 1,8,15 AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, ELSPAR, METHOTREXATE. Patient recovered.